AIIMS-B collaborates with Dutch experts to provide personalized medicine to patients

BHOPAL: AIIMS Bhopal is moving towards the future of healthcare with a new partnership with Erasmus Medical Center Rotterdam, Netherlands. Together they will work on cutting-edge research in pharmacogenomics – the science of how our genes influence how drugs work.For patients, the collaboration promises more personalized treatments. Genetic testing can help doctors determine which drug is best for each person, allowing for safer prescriptions, fewer side effects and faster recovery, rather than relying on giving everyone the same drug.The study aims to evaluate scalability, clinical utility and health economic impact, with the goal of making treatments more personalized and cost-effective.A high-level delegation from Erasmus Medical Center led by Professor Peter J van der Spek, Head of Clinical Bioinformatics, visited AIIMS Bhopal and met Dr. Madhabananda Kar, Director of the Institute. During the meeting, both parties signed a letter of intent to strengthen academic cooperation between the two institutions. The proposed project, worth over Rs 10 crore, will be led by Dr Shubham Atal, professor, Department of Pharmacology, AIIMS Bhopal, who will serve as principal investigator. Professor (PhD) Madhabananda Kar welcomed the initiative, while Professor Peter J. van der Spek highlighted the potential for a strong India-Dutch partnership in the field of precision medicine.